Indices
Nifty 50
ADANIENT2,470.60−3.11% ADANIPORTS1,695.00−3.14% APOLLOHOSP7,584.50−0.26% ASIANPAINT2,266.00−0.82% AXISBANK1,204.90−0.59% BAJAJ-AUTO10,052.00−1.01% BAJAJFINSV1,643.20−2.07% BAJFINANCE919.95−2.35% BEL356.50−2.19% BHARTIARTL1,864.00−1.64% BSE3,208.50−1.73% CIPLA1,319.30−0.87% COALINDIA392.05−2.61% DRREDDY1,226.70−0.99% EICHERMOT6,967.00−1.66% ETERNAL312.10+2.51% GRASIM2,874.90−0.67% HCLTECH1,424.70+0.21% HDFCBANK694.00−0.01% HDFCLIFE517.25−2.10% HINDALCO862.50−2.61% HINDUNILVR1,784.70−2.38% ICICIBANK1,389.00−0.68% INDIGO4,506.00−2.04% INFY1,158.20+0.42% ITC256.85−0.79% JIOFIN203.65−3.39% JSWSTEEL1,194.70−2.07% KOTAKBANK430.85−1.41% LT3,604.80−0.92% M&M2,816.50−1.66% MARUTI11,061.00−0.98% MAXHEALTH816.10−0.11% NESTLEIND1,160.80−2.45% NTPC293.15−3.12% ONGC225.000.00% POWERGRID242.70−2.29% RELIANCE1,172.50−1.01% SBILIFE1,621.60−1.30% SBIN952.40−1.81% SHRIRAMFIN871.35−3.28% SUNPHARMA1,740.40−1.00% TATACONSUM950.20−1.00% TATASTEEL164.05−4.80% TCS2,540.80+1.35% TECHM1,791.90−2.03% TITAN4,219.10−3.01% TMPV260.80−3.41% TRENT2,691.60−3.03% ULTRACEMCO10,861.00−0.89%

Piramal Pharma share price

Piramal Pharma Ltd. · NSE: PPLPHARMA · Healthcare

₹187.74 −7.25 −3.72%
Live · 23 Oct 2026, 12:39 IST

Price, one year

1 year agoLow 133.27 · High 226.62Latest close
1W+0.54%
1M−9.16%
3M+10.10%
6M+29.30%
1Y−1.31%

Price range

Open
₹194.00
High
₹194.91
Low
₹185.02
Previous close
₹194.99
Volume
15.4 L
Market cap
₹24,995 Cr
Day range
52-week range

Key statistics

Results to 30 Jun 2026 · Consolidated
P/E (TTM)
—
Price to book
3.2
Return on equity
−3.8%
EPS (TTM)
₹−2.37
Book value / share
₹61.31
Debt to equity
0.67
Revenue (TTM)
₹9,205 Cr
Net profit (TTM)
₹−314 Cr
Sales growth, YoY
+17.4%
Profit growth, YoY
—
Operating margin
11.0%
Net margin
−3.4%
Sales CAGR, 3 years
+7.8%
Profit CAGR, 3 years
—
Promoter holding
34.80%
Promoter shares pledged
0.00%
From the company's results filed with NSE; TTM is the last four quarters. Ratios use the latest price.

Shareholding pattern

% of shares
HolderSep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters34.8634.8634.8634.8034.80
Foreign institutions30.2729.6630.1812.5213.65
Domestic institutions14.8915.6915.6114.5714.44
Mutual funds13.1114.0314.1213.1812.71
Retail and others14.1114.1113.7414.5413.27

Results and announcements

Latest results (quarter to 30 Jun 2026) filed 29 Jul 2026. results: 27 Oct 2026.

Exchange filings as published on NSE; routine filings are left out.

Peers in Healthcare

All Healthcare stocks
CompanyPriceChangeMarket capP/E
Sun Pharmaceutical IndustriesSUNPHARMA ₹1,740.40 −1.00% ₹4,17,580 Cr 34.9
Divi's LaboratoriesDIVISLAB ₹8,881.00 −3.07% ₹2,35,763 Cr 83.1
Torrent PharmaceuticalsTORNTPHARM ₹4,487.80 −2.76% ₹1,70,701 Cr 73.7
Zydus LifesciencesZYDUSLIFE ₹1,124.80 −0.90% ₹1,12,199 Cr 25.3
Apollo Hospitals EnterpriseAPOLLOHOSP ₹7,584.50 −0.26% ₹1,09,053 Cr 52.3
CiplaCIPLA ₹1,319.30 −0.87% ₹1,06,582 Cr 31.9
Laurus LabsLAURUSLABS ₹1,943.10 −2.97% ₹1,04,988 Cr 98.8
Dr. Reddy's LaboratoriesDRREDDY ₹1,226.70 −0.99% ₹1,02,390 Cr 32.0
Mankind PharmaMANKIND ₹2,228.10 −2.09% ₹92,031 Cr 46.0
Aurobindo PharmaAUROPHARMA ₹1,557.50 −3.31% ₹89,615 Cr 25.2

Frequently asked questions

What is the share price of Piramal Pharma today?

Piramal Pharma (NSE: PPLPHARMA) was at ₹187.74 on 23 Oct 2026, a change of −3.72% from the previous close.

What are the 52-week high and low of Piramal Pharma?

Over the last 52 weeks Piramal Pharma traded between ₹132.30 and ₹231.93 (daily highs and lows on NSE on 23 Oct 2026).

What is the market capitalisation of Piramal Pharma?

About ₹24,995 Cr at the latest price, with a price-to-book of 3.2, a return on equity of −3.8%. Ratios use the company's latest reported results.

Who owns Piramal Pharma shares?

According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 34.80%, foreign institutions 13.65%, domestic institutions 14.44%.

Which sector and indices does Piramal Pharma belong to?

NSE classifies Piramal Pharma under Healthcare; it is a member of Nifty 500.

Follow Piramal Pharma with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.

Get started free